Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

S&P Biotech SPDR (XBI)

S&P Biotech SPDR (XBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Price/Earnings ttm 16.40
  • Annual Dividend & Yield 0.04 (0.04%)
  • Most Recent Dividend 0.027 on 09/22/25
  • Management Fee 0.35%
  • INDUSTRY GROUPING:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 27.78% ( +1.89%)
  • Historical Volatility 21.99%
  • IV Percentile 48%
  • IV Rank 17.58%
  • IV High 56.80% on 04/08/25
  • IV Low 21.59% on 07/24/25
  • Put/Call Vol Ratio 0.19
  • Today's Volume 28,830
  • Volume Avg (30-Day) 50,689
  • Put/Call OI Ratio 0.94
  • Today's Open Interest 849,810
  • Open Int (30-Day) 782,710

Price Performance

See More
Period Period Low Period High Performance
1-Month
103.43 +10.17%
on 10/14/25
114.96 -0.88%
on 11/12/25
+8.96 (+8.53%)
since 10/10/25
3-Month
87.27 +30.57%
on 08/13/25
114.96 -0.88%
on 11/12/25
+27.03 (+31.10%)
since 08/12/25
52-Week
66.66 +70.94%
on 04/09/25
114.96 -0.88%
on 11/12/25
+13.44 (+13.37%)
since 11/12/24

Most Recent Stories

More News
Biotech Sector May Flip to Market Leader by Year-End

As rate cuts loom and after years of lagging, the biotech sector is showing signs of life, with IBB outpacing the benchmark S&P 500 on the quarter.

IBB : 164.98 (+0.51%)
GILD : 124.57 (+1.64%)
XBI : 113.80 (-0.18%)
IWM : 243.78 (-0.19%)
Biogen Stock: Analyst Estimates & Ratings

Biogen has lagged the broader market over the past year, yet analysts maintain a cautiously optimistic outlook on the stock’s future performance.

$SPX : 6,843.19 (-0.05%)
XBI : 113.80 (-0.18%)
BIIB : 161.83 (+1.42%)
How Is Incyte’s Stock Performance Compared to Other Biotech Stocks?

Incyte has underperformed relative to its biotech peers over the past year, though Wall Street analysts maintain a cautiously optimistic view on the stock’s outlook.

INCY : 108.01 (-0.14%)
EXEL : 43.00 (+0.07%)
XBI : 113.80 (-0.18%)
How Is Vertex Pharmaceuticals’ Stock Performance Compared to Other Biotech Stocks?

Vertex Pharmaceuticals has outperformed its biotech peers over the past year, yet Wall Street analysts maintain a reasonably optimistic outlook on its future potential.

VRTX : 431.60 (+0.55%)
REGN : 688.89 (+2.13%)
XBI : 113.80 (-0.18%)
Best Biotech Stocks to Buy in 2025

Discover the best biotech stocks of 2025, including top performers like Vertex and Regeneron, driven by clinical breakthroughs and strong investor momentum.

VRTX : 431.60 (+0.55%)
AKRO : 54.26 (+0.02%)
REGN : 688.89 (+2.13%)
XBI : 113.80 (-0.18%)
Why Summit Therapeutics Rallied Double Digits Today on Another Down day for the Markets

Shares of lung cancer-focused biotech Summit Therapeutics (NASDAQ: SMMT) rallied 16.6% at its highs of the day before settling into a 10.4% gain on Thursday as of 3:54 p.m. EDT, even though the broader...

SMMT : 18.87 (-1.51%)
XBI : 113.80 (-0.18%)
Retail Traders Mostly Bullish On Biotech Stocks Amid Blow From RFK Jr. Purge On Health Agencies

The sector's recent slide follows Peter Marks' resignation last week as the Food and Drug Administration's top vaccine regulator following a clash with Kennedy.

TECH : 60.43 (+2.11%)
VRTX : 431.60 (+0.55%)
MRNA : 26.17 (-0.91%)
REGN : 688.89 (+2.13%)
XBI : 113.80 (-0.18%)
Soleno Therapeutics Stock Rockets 34% Pre-Market After FDA Approves Prader-Willi Syndrome Drug: Retail Sentiment Peaks

The company expects the drug, the first approved therapy to address hyperphagia in PWS patients, to be available in the U.S. starting April 2025.

VTI : 335.31 (-0.13%)
SLNO : 48.67 (-0.06%)
XBI : 113.80 (-0.18%)
Sarepta Therapeutics Stock Has A Nightmarish Week After DMD Patient Death, But Retail And Analysts Aren't Giving Up

Jefferies acknowledged acute liver failure could signal a new safety risk but maintained that the high unmet need for DMD treatments supports the bull case.

SRPT : 17.79 (-1.06%)
IJH : 65.58 (+0.38%)
VTI : 335.31 (-0.13%)
XBI : 113.80 (-0.18%)
Capricor Therapeutics Stock Surges After Q4 Results Beat Estimates: Retail Gets More Bullish

The company said its available cash, cash equivalents, and marketable securities will be sufficient to cover the expenses and capital requirements into 2027.

VTI : 335.31 (-0.13%)
XBI : 113.80 (-0.18%)
CAPR : 6.26 (+0.97%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

See More

Key Turning Points

3rd Resistance Point 120.22
2nd Resistance Point 117.18
1st Resistance Point 115.60
Last Price 113.89
1st Support Level 110.98
2nd Support Level 107.94
3rd Support Level 106.36

See More

52-Week High 114.96
Last Price 113.89
Fibonacci 61.8% 96.51
Fibonacci 50% 90.81
Fibonacci 38.2% 85.11
52-Week Low 66.66

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar